T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Kopin
KOPN
$935M
| $156K | ﹤0.01% |
211,200
+31,500
| +18% | +$28.9K |
|
2727
Stereotaxis
STXS
$142M
| $156K | ﹤0.01% |
76,199
| – | – |
|
2728
Daktronics
DAKT
$989M
| $154K | ﹤0.01% |
11,853
+154
| +1% | +$2.13K |
|
2729
GrowGeneration
GRWG
$102M
| $153K | ﹤0.01% |
71,385
| – | – |
|
2730
Humacyte
HUMA
$179M
| $153K | ﹤0.01% |
28,069
| – | – |
|
2731
Organogenesis Holdings
ORGO
$234M
| $153K | ﹤0.01% |
53,439
+2,488
| +5% | +$6.98K |
|
|
KALV
2732
DELISTED
KalVista Pharmaceuticals
KALV
| $152K | ﹤0.01% |
13,117
-12,235
| -48% | -$154K |
|
2733
American Well
AMWL
$217M
| $151K | ﹤0.01% |
15,905
| – | – |
|
2734
Frontier Group Holdings
ULCC
$1.55B
| $151K | ﹤0.01% |
28,146
+655
| +2% | +$2.56K |
|
2735
Varex Imaging
VREX
$780M
| $151K | ﹤0.01% |
12,604
+276
| +2% | +$3.52K |
|
|
DM
2736
DELISTED
Desktop Metal, Inc.
DM
| $151K | ﹤0.01% |
32,229
-1
| -0% | -$5 |
|
|
LGF.A
2737
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $150K | ﹤0.01% |
19,117
+358
| +2% | +$3K |
|
|
PTVE
2738
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $150K | ﹤0.01% |
12,968
+207
| +2% | +$2.38K |
|
2739
CorMedix
CRMD
$685M
| $149K | ﹤0.01% |
18,415
+2,334
| +15% | +$12.6K |
|
2740
Altimmune
ALT
$560M
| $148K | ﹤0.01% |
23,988
+1,320
| +6% | +$8.94K |
|
2741
Butterfly Network
BFLY
$2.53B
| $148K | ﹤0.01% |
83,400
| – | – |
|
|
FPI
2742
Farmland Partners
FPI
$430M
| $148K | ﹤0.01% |
14,138
+278
| +2% | +$2.94K |
|
|
RPC
2743
Ridgepost Capital
RPC
$997M
| $148K | ﹤0.01% |
13,729
+1,121
| +9% | +$11K |
|
|
AGS
2744
DELISTED
PlayAGS
AGS
| $144K | ﹤0.01% |
12,589
+198
| +2% | +$2.25K |
|
2745
Bioventus
BVS
$1.16B
| $144K | ﹤0.01% |
12,041
| – | – |
|
2746
NewtekOne
NEWT
$378M
| $144K | ﹤0.01% |
11,482
+190
| +2% | +$2.41K |
|
|
TWKS
2747
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $144K | ﹤0.01% |
32,408
+1,325
| +4% | +$5.09K |
|
2748
Bit Digital
BTBT
$558M
| $143K | ﹤0.01% |
40,457
+3,087
| +8% | +$10.3K |
|
|
MPX
2749
DELISTED
Marine Products Corp
MPX
| $143K | ﹤0.01% |
14,668
| – | – |
|
2750
The ONE Group
STKS
$56.5M
| $143K | ﹤0.01% |
38,790
+1,995
| +5% | +$8.02K |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.